Jill is a strategic expert with 30+ years of big business leadership, uniquely skilled in the complete facets of oncology marketing and commercialization.

 

She is a bio-pharmaceutical executive leader with demonstrated success in global oncology strategy, commercial management and execution. She has overseen successful oncology product launches, brand and organization strategy, marketing teams, as well as licensing and investment prioritization,

go-to-market strategy.

 

Jill spent her career focusing on the Oncology therapeutic area launching some of the most successful chemotherapy and targeted therapies in the industry as well overseeing the commercial pipeline development process.

​

She has worked for industry leaders developing an award winning track record of success in marketing, sales and leadership management including Bristol-Myers Squib, Agenus, Pharmion/Celgene, Schering/Merck and Teva.

 

Her experience includes working for big pharma, innovative biotechs, small pharma while leading teams focused specialty medicines, vaccines,

biosimilars and generics.